Phenotyping Patient Samples and Healthy Controls
Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls
9
High-risk human papillomavirus (HPV) screening and detection in healthy patient saliva samples: a pilot study
8
Pituitary Iron and Volume Imaging in Healthy Controls
7
Dietary patterns and schizophrenia: a comparison with healthy controls
6
A large, consistent plasma proteomics data set from prospectively collected breast cancer patient and healthy volunteer samples
11
A large, consistent plasma proteomics data set from prospectively collected breast cancer patient and healthy volunteer samples
13
Deep Learning Methods for Patient Phenotyping from Electronic Health Records
64
Neurocognition and Disability in Patients with Schizophrenia compared with Healthy Controls
124
Body composition in patients with schizophrenia: Comparison with healthy controls
5
The Gut and Blood Microbiome in IgA Nephropathy and Healthy Controls
Serum Osteoprotegerin Levels in Healthy Controls and Cancer Patients
5
Personality styles in patients with fibromyalgia, major depression and healthy controls
6
Comparison of periodontal parameters among cardiovascular patients and healthy controls
6
Differences in the experience of fatigue in patients and healthy controls: patients' descriptions
7
Immunological and morphological analysis of heterotopic ossification differs to healthy controls
7
Swallowing in Parkinson patients versus healthy controls: reliability of measurements in videofluoroscopy
10
Deciphering the peptidome of urine from ovarian cancer patients and healthy controls
10
Lexical Differences in Autobiographical Narratives from Schizophrenic Patients and Healthy Controls
11
Extracranial Venous Drainage Patterns in Patients with Multiple Sclerosis and Healthy Controls
6
Level of daily physical activity in individuals with COPD compared with healthy controls
8